搜索筛选:
搜索耗时0.0767秒,为你在为你在102,285,761篇论文里面共找到 4 篇相符的论文内容
发布年度:
[期刊论文] 作者：Glynis P Ross,Henrik Falhammar,Roger Chen,Helen Barraclough,Ole Kleivenes,Ian Gallen,,
来源：World Journal of Diabetes 年份：2016
AIM To systematically review the literature on women with both diabetes in pregnancy(DIP) and depression during or after pregnancy. METHODS In this systematic l...
Pemetrexed continuation maintenance: An effective tolerable strategy for treating nonsquamous non-sm
[会议论文] 作者：James Chih-Hsin Yang,Myung-Ju Ahn,Kazuhiko Nakagawa,Tomohide Tamura,Helen Barraclough,Sotaro Enatsu,Rebecca,
来源：第十七届全国临床肿瘤学大会暨2014年CSCO学术年会 年份：2014
...
Pemetrexed continuation maintenance: An effective tolerable strategy for treating nonsquamous non-sm
[会议论文] 作者：James Chih-Hsin Yang,Myung-Ju Ahn,Kazuhiko Nakagawa,Tomohide Tamura,Helen Barraclough,Sotaro Enatsu,Rebecca,
来源：第十七届全国临床肿瘤学大会暨2014年CSCO学术年会 年份：2014
Objective: A recent phase 3 study (PARAMOUNT) demonstrated that continuation maintenance therapy of pemetrexed is a new treatment paradigm for advanced nonsquamous NSCLC.The majority of patients enrol...
[会议论文] 作者：Yi-Long Wu,Shun Lu,Ying Cheng,Caicun Zhou,Mengzhao Wang,Shukui Qin,You Lu,Yang Zhang,Yunzhong Zhu,Helen Barraclough,
来源：第十六届全国临床肿瘤学大会暨2013年CSCO学术年会 年份：2013
目的: It has been demonstrated that pemetrexed/cisplatin (A/C) has superior survival benefit and better safety profile over standard first line chemotherapy with gemcitabine/cisplatin (G/C) in patients...
相关搜索：
